Cedars-Sinai Medical Center
$50,000 Tower Career Development Grant
Research Title:
Novel Gene Discovery and Classification for Mantle Cell Lymphoma
Examining a large number of samples and associating the genetic abnormalities with the clinical data will permit us to develop new diagnostic subcategorization of this heterogeneous group of diseases, provide prognostic indicators for the patient and physicians, and identify targets for small molecule therapy. Because of its ease and robustness, the 500K SNP chip may become the standard of care for diagnosis, prognosis, and monitoring progession of MCL, as well as other malignancies.